Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted ...

Tracking the trajectory of symptoms may be an improvement over the traditional way of collecting patient-reported outcomes ...

Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based ...

FDA approves Ibtrozi for ROS1+ non-small cell lung cancer based on data from over 300 patients in two pivotal trials showing ...